MentionFox
Home › Executive changes › Becton Dickinson & Co
Leadership changes · BDX · SEC Form 8-K, Item 5.02

Leadership changes at Becton Dickinson & Co (2026)

Before you join, sell to or invest in Becton Dickinson & Co

MentionFox check on Becton Dickinson & Co: no red flags found in 5 sources; 1 item to note (checked 6 November 2026). mentionfox.com/c/executive-changes/becton-dickinson-and

  • Note: Layoff notice filed Sep 2026 (about 85 employees in CA) (state notice)

Check Becton Dickinson & Co before you join, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Becton Dickinson & Co?

Who joined and who left Becton Dickinson & Co (BDX)? 2 departures reported from 2026-04-09 to 2026-07-22, each cited to the company's own filing.

Michael D. Garrison's departure as Executive Vice President of Becton Dickinson & Co was reported; the filing names no successor. As of November 6, 2026, Becton Dickinson & Co has reported 3 leadership change filings to the SEC under Item 5.02 of Form 8-K, from April 9, 2026 to July 22, 2026, naming 2 departures (Form 8-K, July 22, 2026).

30 companies changed executives this week.

Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.

John Hancock Comvest Private Income Fundnamed a new Chief Financial Officer
Bain Capital Specialty Finance, Inc.named a new Director
Azora Therapeutics, Inc. (DE)named a new Director
LASE Corp.named a new Director
Century Communities, Inc.named a new Executive Chairman
Check one company free

First Eagle Investment Management, LLC also filed stake reports on 16 other companies ↓

Sell to companies like Becton Dickinson & Co? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Key facts

  • · In / out: Out · Person: Michael D. Garrison · Role: Executive Vice President · 8-K, 2026-07-22
  • · In / out: Reported · Person: not named in the filing · 8-K/A, 2026-05-07
  • · In / out: Out · Person: Richard E. Byrd · Role: Executive Vice President · 8-K, 2026-04-09
Changes3
Out (departing)2
Latest filing2026-07-22

Becton Dickinson & Co reported changes in 3 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-04-09 to 2026-07-22. They name 2 people. Every row below is cited to the filing it comes from, and this page adds each new change as Becton Dickinson & Co files it.

Also on the record for Becton Dickinson & Co

DateRecordFigureOur pageSource
August 7, 2026Stake report, Schedule 13G, by STATE STREET CORPORATION5.4% of the class5%+ stakesSource
August 6, 2026Stake report, Schedule 13G, by First Eagle Investment Management, LLC5.1% of the class5%+ stakesSource
May 15, 2026Stake report, Schedule 13G/A, by T. Rowe Price Investment Management, Inc.3.4% of the class5%+ stakesSource
April 29, 2026Stake report, Schedule 13G, by Vanguard Capital Management7.51% of the class5%+ stakesSource
April 29, 2026Stake report, Schedule 13G, by Vanguard Portfolio Management5.4% of the class5%+ stakesSource
March 26, 2026Stake report, Schedule 13G/A, by The Vanguard Group—5%+ stakesSource
January 30, 2026Stake report, Schedule 13G/A, by The Vanguard Group12.85% of the class5%+ stakesSource
August 14, 2025Stake report, Schedule 13G, by T. Rowe Price Investment Management, Inc.5.6% of the class5%+ stakesSource
July 7, 2025Stake report, Schedule 13G/A, by The Vanguard Group11.27% of the class5%+ stakesSource

Selling to them or working with them? See who runs Becton Dickinson & Co now and the warning signs.

Free to see. No signup.

Keep reading

More on Becton Dickinson & Co and the records around it.

Becton Dickinson & Co elsewhere on the record

Companies that share a holder

Want the whole picture on Becton Dickinson & Co?

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Becton Dickinson & Co: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Becton Dickinson & Co covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    13 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

Timeline

FiledIn / outPersonRoleEffectiveSource
2026-07-22OutExecutive Vice President8-K, 2026-07-22
2026-05-07Reportednot named in the filing8-K/A, 2026-05-07
2026-04-09OutExecutive Vice President8-K, 2026-04-09

Who leads Becton Dickinson & Co, as last reported?

For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.

Selling to Becton Dickinson & Co?

New leaders reset buying decisions — get the Full Report on Becton Dickinson & Co: who runs it, how the money works and what to watch, every claim linked to its source.

Get the Full Report

Watch Becton Dickinson & Co

Hiring for a seat like this?

Find people with the same kind of experience as the Executive Vice President at Becton Dickinson & Co, with the record behind each one.

Find candidates like Executive Vice President at Becton Dickinson & Co

Every change, in the filing's words

Filed 2026-07-22 · 8-K

Departing: Michael D. Garrison, Executive Vice President

On July 19, 2026, Michael D. Garrison, Executive Vice President and President of the Medical Essentials and BioPharma Systems segments of Becton, Dickinson and Company ("BD"), informed BD of his intention to retire.

Also stated in this filing

  • Dr. Garrison will remain in his role through the end of the fiscal year to support a smooth transition.
  • A comprehensive search is underway to identify the next President of the Medical Essentials segment.
  • Going forward, to streamline BD's operating model, the BioPharma Systems segment will report directly to Thomas E. Polen, Chairman, CEO and President of BD.
Filed 2026-05-07 · 8-K/A

Reported

Effective May 7, 2026 (the "Effective Date"), the Company's Board of Directors (the "Board") approved the appointment of Mr. Roque as the Company's Executive Vice President and Chief Financial Officer.

Also stated in this filing

  • In connection with this appointment, the Company's Compensation and Human Capital Committee (the "Compensation Committee") approved an annual base salary for Mr. Roque of $770,000, an annual target bonus equal to 95% of his base salary, pro-rated for the fiscal year ending September 30, 2026 to account for his change in salary and bonus target, and an annual equity compensation award target value of $3,000,000, each effective as of the Effective Date.
  • In addition, in recognition of Mr. Roque's service as interim Chief Financial Officer, the Company's Compensation Committee approved a cash payment of $250,000 and a grant of time-vested units valued at $250,000, both to be awarded as of the Effective Date.
  • The equity awards referred to herein are subject to Mr. Roque's continued service through each applicable vesting date and the other terms and conditions of the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan (the "2004 Plan").
  • Mr. Roque will continue to be eligible to participate in severance, retirement, welfare and benefit plans and programs generally available to other employees and executive officers of the Company.
Filed 2026-04-09 · 8-K

Departing: Richard E. Byrd, Executive Vice President

On April 6, 2026, Richard E. Byrd, Executive Vice President and President of the Interventional segment of Becton, Dickinson and Company ("BD"), informed BD of his intention to retire.

Also stated in this filing

  • Mr. Byrd will remain in his role through June.
  • BD intends to name a successor to Mr. Byrd prior to his retirement date.

Tools for this story

Each opens in a new tab, filled in for Becton Dickinson & Co. With no account yet, you sign up free and land on the result.

Where this comes from

A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.

Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.

Not for employment, credit or tenancy decisions. MentionFox research is for sales, partnership and investor research. Permitted use

Cite this page

Permanent URL: https://mentionfox.com/executive-changes/becton-dickinson-and
Last updated 2026-11-06
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4 · California WARN file
Who left Becton Dickinson & Co? Leadership changes (2026). MentionFox, 2026-11-06. https://mentionfox.com/executive-changes/becton-dickinson-and